Oncologists’ and cancer patients’ views on whole-exome sequencing and incidental findings: results from the CanSeq study

The right to know and genetic testing

(2015) Mark Sheehan   JOURNAL OF MEDICAL ETHICS

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

(2015) Donavan T. Cheng et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center

(2015) Barbara A. Parker et al.   Journal of Oncology Practice

Clinical Tumor Sequencing: An Incidental Casualty of the American College of Medical Genetics and Genomics Recommendations for Reporting of Incidental Findings

(2014) D. Williams Parsons et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Genomics and Inherited Risk

(2014) Zsofia K. Stadler et al.   JOURNAL OF CLINICAL ONCOLOGY

Physicians' Attitudes About Multiplex Tumor Genomic Testing

(2014) Stacy W. Gray et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Enterprise-Level Molecular Genotyping of a Cohort of Cancer Patients

(2014) Laura E. MacConaill et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

(2014) Eliezer M Van Allen et al.   NATURE MEDICINE

Experiences and attitudes of genome investigators regarding return of individual genetic test results

(2013) Rachel B. Ramoni et al.   GENETICS IN MEDICINE

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Clinical Analysis and Interpretation of Cancer Genome Data

(2013) Eliezer M. Van Allen et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacogenetics in clinical practice: how far have we come and where are we going?

(2013) Julie A Johnson   PHARMACOGENOMICS

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

(2011) M V Relling et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Personalizing medicine with clinical pharmacogenetics

(2011) Stuart A. Scott   GENETICS IN MEDICINE

Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study

(2011) S. Roychowdhury et al.   Science Translational Medicine

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2010) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of Screening Questions for Limited Health Literacy in a Large VA Outpatient Population

(2008) Lisa D. Chew et al.   JOURNAL OF GENERAL INTERNAL MEDICINE